Skip to main content

Table 2 Risk factor values for patients who had above-target values at baseline

From: Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study

 

Intervention

Control

p-value

LDL-C ≥ 2.5/1.8a baseline, n

87

78

 

LDL-C baseline, median (25th–75th percentile)

2.9 (2.6–3.5)

2.9 (2.7–3.7)

0.74

LDL-C 12 months, median (25th–75th percentile)

2.2 (1.8–3.0)***

3.0 (2.4–3.4)**

<0.001

SBP ≥ 140 baseline, n

89

95

 

SBP baseline, median (25th–75th percentile)

150 (142–160)

150 (140–160)

0.97

SBP 12 months, median (25th–75th percentile)

140 (129–155)***

145 (130–158)***

0.26

DBP ≥ 90 baseline, n

25

26

 

DBP baseline, median (25th–75th percentile)

90 (90–95)

90 (90–96)

0.71

DBP 12 months, median (25th–75th percentile)

80 (75–86)***

80 (75–91)***

0.48

  1. **p ≤ 0.01, ***p ≤ 0.001, indicating a significant change of median values within each group between baseline and 12 months; a The target LDL-C value was <2.5 mmol/L until 31 March, 2013, when local guidelines for diabetic patients changed this target to <1.8 mmol/L. LDL-C low-density lipoprotein cholesterol (mmol/L), n number of cases, SBP systolic blood pressure (mmHg), DBP diastolic blood pressure (mmHg)